WA
REGN icon

WESPAC Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

WESPAC Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-222
Closed -$233K – 164
2024
Q2 		$233K Sell
222
-93
-30% -$90.2K 0.18% 135
2024
Q1 		$303K Sell
315
-4
-1% -$3.8K 0.18% 137
2023
Q4 		$280K Sell
319
-16
-5% -$13.2K 0.19% 122
2023
Q3 		$276K Buy
+335
New +$263K 0.21% 114
2023
Q2 		– Sell
-272
Closed -$223K – 129
2023
Q1 		$223K Buy
+272
New +$205K 0.21% 98
2020
Q3 		– Sell
-339
Closed -$211K – 107
2020
Q2 		$211K Buy
+339
New +$192K 0.24% 97
2016
Q1 		– Sell
-1,347
Closed -$731K – 121
2015
Q4 		$731K Buy
1,347
+516
+62% +$280K 0.85% 56
2015
Q3 		$387K Sell
831
-313
-27% -$168K 0.68% 45
2015
Q2 		$584K Buy
+1,144
New +$558K 0.44% 73

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return